How to Help Your Patients Find Mycophenolate Mofetil in Stock: A Provider's Guide

The mycophenolate mofetil (MMF) shortage puts transplant coordinators, rheumatologists, nephrologists, and their clinical teams in a difficult position. When patients call saying they can't fill their prescription, the response needs to be fast, organized, and clinically appropriate — while also not overwhelming an already-busy practice.

This guide is built for prescribers and care teams. It outlines the specific steps you can take — and the tools and resources you can point patients toward — to help them locate their medication quickly while managing the clinical risks of any potential supply gap.

Why This Matters: High Stakes for MMF-Dependent Patients

Mycophenolate mofetil is one of the most widely prescribed immunosuppressants in the United States. It's used long-term — often indefinitely — in solid organ transplant recipients to prevent rejection, and in millions of autoimmune patients to prevent disease flares. There is no safe 'drug holiday' from MMF for high-risk patients.

For transplant recipients, even short gaps in immunosuppression increase the risk of acute rejection. For lupus nephritis patients, interruption can trigger severe renal flares requiring IV corticosteroids or rescue cytotoxic therapy. The provider's role in helping patients navigate the shortage is not optional — it is a patient safety function.

Step 1: Proactively Identify At-Risk Patients Before They Run Out

Don't wait for patients to call you in a panic. Run a report from your EHR to identify all patients currently on mycophenolate mofetil prescriptions. Flag those who:

• Are within 30 days of needing a refill
• Are in their first year post-transplant (highest rejection risk)
• Have a history of prior rejection or non-adherence
• Are on a 30-day supply and filling at retail pharmacies rather than mail-order or specialty pharmacy

For high-risk patients, consider proactive outreach — a message through your patient portal or a call from your nurse — letting them know about the shortage and instructing them to refill early.

Step 2: Know the Formulation Options You Can Offer

Providing patients with options — not just a 'sorry, try other pharmacies' — requires knowing the full menu of formulations available:

• Brand-name CellCept (Genentech): Generally more available than generics. Have a Genentech CellCept savings card conversation ready — eligible commercially-insured patients can pay as low as $15/month.
• Different strengths: If 500 mg tablets are unavailable, 250 mg capsules can be substituted at an equivalent total dose. Write an explicit prescription for the capsule form if needed.
• Mycophenolate sodium (Myfortic, EC-MPS): Myfortic 720 mg twice daily is approximately equivalent to mycophenolate mofetil 1 g twice daily. Write a new prescription with the explicit Myfortic dose — do not rely on pharmacy conversion without a provider-written order.
• Myhibbin oral suspension: The 200 mg/mL ready-to-use oral suspension approved in 2024 is appropriate for patients who cannot swallow solid oral formulations. Consider this for elderly patients or those with swallowing difficulties.

Step 3: Direct Patients to Effective Pharmacy Search Tools

One of the most practical things you can do is give patients a clear resource for finding their medication. medfinder calls pharmacies in the patient's area to check which ones have the medication in stock, then texts the patient the results. This removes the burden of calling dozens of pharmacies from both the patient and your care team.

Other tools to recommend:

• Hospital outpatient pharmacy: For transplant patients, the outpatient pharmacy affiliated with your hospital or transplant center often maintains dedicated immunosuppressant inventory. This should be the first call for post-transplant patients.
• Specialty pharmacies: Amber Specialty, AllianceRx Walgreens, CVS Specialty, and other specialty pharmacies often maintain larger inventories and have established relationships with transplant centers.
• Mail-order pharmacy: Encourage 90-day mail-order fills through the patient's insurance when available. Express Scripts, CVS Caremark, OptumRx, and others typically have more consistent supply than retail pharmacies.

Step 4: Create a Shortage Response Protocol for Your Practice

Documenting a shortage response protocol in your practice reduces the burden on individual providers and ensures consistent, rapid responses when patients call with shortage issues:

1. Define which nurses/coordinators can authorize formulation switches (brand-name CellCept, different strength) without a physician appointment
2. Pre-write Myfortic dose conversion instructions for common MMF doses (e.g., 1g BID MMF → Myfortic 720mg BID)
3. List approved specialty pharmacies your practice can route patients to during shortages
4. Define clinical thresholds for escalation (e.g., transplant patient without MMF for >48 hours should trigger urgent review)
5. Share patient-facing guidance with your front desk staff so they can direct callers appropriately

Patient-Facing Resources to Share

Give your patients these specific resources when they face a shortage:

• medfinder.com — Calls pharmacies near them to find which ones have their medication in stock
• GoodRx and SingleCare — Discount coupons if switching to brand-name or different formulation changes cost
• Genentech patient support: 1-888-835-2555 for CellCept savings programs and patient assistance
• PAN Foundation patient assistance program for qualifying uninsured or underinsured patients

For additional provider guidance on the shortage, see: Mycophenolate Mofetil Shortage: What Providers and Prescribers Need to Know in 2026. For cost savings programs: How to Help Your Patients Save Money on Mycophenolate Mofetil.